Safety and efficacy of inhaled GM-CSF (molgramostim) in autoimmune pulmonary alveolar proteinosis—the IMPALA trial—baseline data and blinded treatment period results.

Home / Safety and efficacy of inhaled GM-CSF (molgramostim) in autoimmune pulmonary alveolar proteinosis—the IMPALA trial—baseline data and blinded treatment period results.

See presentation

We use cookies to give you the best online experience. By accepting, you agree to the use of cookies in accordance with our cookie policy.

I Accept I Decline